Association between dietary macronutrient composition and plasma one-carbon metabolites and B-vitamin cofactors in patients with stable angina pectoris

• Published in: British journal of nutrition 2024-05, Vol.131 (10), p.1678-1690
• Main Authors: Bråtveit, Marianne, Van Parys, Anthea, Olsen, Thomas, Strand, Elin, Marienborg, Ingvild, Laupsa-Borge, Johnny, Haugsgjerd, Teresa Risan, McCann, Adrian, Dhar, Indu, Ueland, Per Magne, Dierkes, Jutta, Dankel, Simon Nitter, Nygård, Ottar Kjell, Lysne, Vegard
• Format: Article
• Language: English
• Subjects: Angina; Angina pectoris; Carbohydrates; Carbon; Cardiovascular disease; Composition; Dehydrogenases; Diet; Energy; Energy intake; Enzymes; Fatty acids; Folic acid; Food; Grain; Homocysteine; Metabolism; Metabolism and Metabolic Studies; Metabolites; Microbiological assaying; Nutrition research; Oxidation; Phenotypes; Plasma; Proteins; Riboflavin; Vitamin B; Vitamin B12
• ISSN: 0007-1145; 1475-2662
• DOI: 10.1017/S0007114524000473

Elevated plasma concentrations of several one-carbon metabolites are associated with increased CVD risk. Both diet-induced regulation and dietary content of one-carbon metabolites can influence circulating concentrations of these markers. We cross-sectionally analysed 1928 patients with suspected stable angina pectoris (geometric mean age 61), representing elevated CVD risk, to assess associations between dietary macronutrient composition (FFQ) and plasma one-carbon metabolites and related B-vitamin status markers (GC–MS/MS, LC–MS/MS or microbiological assay). Diet-metabolite associations were modelled on the continuous scale, adjusted for age, sex, BMI, smoking, alcohol and total energy intake. Average (geometric mean (95 % prediction interval)) intake was forty-nine (38, 63) energy percent (E%) from carbohydrate, thirty-one (22, 45) E% from fat and seventeen (12, 22) E% from protein. The strongest associations were seen for higher protein intake, i.e. with higher plasma pyridoxal 5’-phosphate (PLP) (% change (95 % CI) 3·1 (2·1, 4·1)), cobalamin (2·9 (2·1, 3·7)), riboflavin (2·4 (1·1, 3·7)) and folate (2·1 (1·2, 3·1)) and lower total homocysteine (tHcy) (–1·4 (–1·9, −0·9)) and methylmalonic acid (MMA) (–1·4 (–2·0, −0·8)). Substitution analyses replacing MUFA or PUFA with SFA demonstrated higher plasma concentrations of riboflavin (5·0 (0·9, 9·3) and 3·3 (1·1, 5·6)), tHcy (2·3 (0·7, 3·8) and 1·3 (0·5, 2·2)) and MMA (2·0 (0·2, 3·9) and 1·7 (0·7, 2·7)) and lower PLP (–2·5 (–5·3, 0·3) and −2·7 (–4·2, −1·2)). In conclusion, a higher protein intake and replacing saturated with MUFA and PUFA were associated with a more favourable metabolic phenotype regarding metabolites associated with CVD risk.